New score aims to guide tough chemo decisions for advanced breast cancer
NCT ID NCT01574170
First seen Apr 24, 2026 · Last updated May 24, 2026 · Updated 4 times
Summary
This study involved 267 women with metastatic breast cancer who were starting a third round of chemotherapy. Researchers created a scoring system using clinical, lab, and tumor cell data to predict which patients would live longer with this treatment. The goal is to help doctors and patients make more informed decisions about continuing chemotherapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER STARTING A THIRD LINE CHEMOTHERAPY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
C.M.C.O. Claude Bernard
Albi, 81000, France
-
CHRU Brest
Brest, 26609, France
-
CHU Jean Minjoz
Besançon, 25030, France
-
CHU Rangueil
Toulouse, 31000, France
-
Centre Eugène Marquis
Rennes, 35042, France
-
Centre Georges François Leclerc
Dijon, 21079, France
-
Centre Hospitalier Intercommunal de Castres-Mazamet
Castres, 81108, France
-
Centre Hospitalier Jean Rougier
Cahors, 46005, France
-
Centre Hospitalier de Rodez
Rodez, 12000, France
-
Centre Paul Strauss
Strasbourg, 67065, France
-
Centre d'Oncologie et de Radiothérapie du Parc
Dijon, 21000, France
-
Clinique La Croix du Sud
Quint-Fonsegrives, 31130, France
-
Institut Claudius Regaud
Toulouse, 31052, France
-
Institut de Cancérologie de Lorraine
Vandœuvre-lès-Nancy, 54519, France
-
Institut de Cancérologie de l'Ouest Paul Papin
Angers, 49933, France
-
Polyclinique de l'Ormeau
Tarbes, 65000, France
Conditions
Explore the condition pages connected to this study.